IRIS Accounts Production v24.3.2.46 09853305 Board of Directors 1.6.23 31.5.24 31.5.24 4.2.2025 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098533052023-05-31098533052024-05-31098533052023-06-012024-05-31098533052022-05-31098533052022-06-012023-05-31098533052023-05-3109853305ns15:EnglandWales2023-06-012024-05-3109853305ns14:PoundSterling2023-06-012024-05-3109853305ns10:Director12023-06-012024-05-3109853305ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3109853305ns10:SmallEntities2023-06-012024-05-3109853305ns10:Audited2023-06-012024-05-3109853305ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3109853305ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3109853305ns10:FullAccounts2023-06-012024-05-3109853305ns10:OrdinaryShareClass12023-06-012024-05-3109853305ns10:Director22023-06-012024-05-3109853305ns10:Director32023-06-012024-05-3109853305ns10:Director42023-06-012024-05-3109853305ns10:RegisteredOffice2023-06-012024-05-3109853305ns5:CurrentFinancialInstruments2024-05-3109853305ns5:CurrentFinancialInstruments2023-05-3109853305ns5:ShareCapital2024-05-3109853305ns5:ShareCapital2023-05-3109853305ns5:RetainedEarningsAccumulatedLosses2024-05-3109853305ns5:RetainedEarningsAccumulatedLosses2023-05-3109853305ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3109853305ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3109853305ns10:OrdinaryShareClass12024-05-31
REGISTERED NUMBER: 09853305 (England and Wales)



















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MAY 2024

FOR

THE MEDICAL & DIAGNOSTIC CARE GROUP LTD

THE MEDICAL & DIAGNOSTIC CARE GROUP LTD (REGISTERED NUMBER: 09853305)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


THE MEDICAL & DIAGNOSTIC CARE GROUP LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MAY 2024







DIRECTORS: J P Brown
I Oxley
Mrs P E Jarvis
D S Simpkin



REGISTERED OFFICE: Amlin House
90-96 Victoria Road
Chelmsford
Essex
CM11QU



REGISTERED NUMBER: 09853305 (England and Wales)



AUDITORS: ESW Limited
Chartered Accountants
& Registered Auditors
162-164 High Street
Rayleigh
Essex
SS6 7BS



BANKERS: HSBC Bank PLC
Coventry DSC
Harry Weston Road
Binley
Coventry
CV3 2TQ

THE MEDICAL & DIAGNOSTIC CARE GROUP LTD (REGISTERED NUMBER: 09853305)

BALANCE SHEET
31ST MAY 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 1,822,579 2,033,876
Cash at bank and in hand 99,529 182,242
1,922,108 2,216,118
CREDITORS
Amounts falling due within one year 5 (1,916,277 ) (2,100,644 )
NET CURRENT ASSETS 5,831 115,474
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,831

115,474

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 5,731 115,374
SHAREHOLDERS' FUNDS 5,831 115,474

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4th February 2025 and were signed on its behalf by:





Mrs P E Jarvis - Director


THE MEDICAL & DIAGNOSTIC CARE GROUP LTD (REGISTERED NUMBER: 09853305)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

1. STATUTORY INFORMATION

The Medical & Diagnostic Care Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and trade discounts.

Turnover from the rendering of services is recognised in ther period in which the service has been completed.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12
'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including trade and other creditors and bank loans, are initially recognised at
transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is
measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Equity instruments
Equity instruments issued by the company are recorded at the fair value of proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.


THE MEDICAL & DIAGNOSTIC CARE GROUP LTD (REGISTERED NUMBER: 09853305)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2023 - 10 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 975,513 1,051,900
Amounts owed by group undertakings 600,836 675,778
Other debtors 246,230 306,198
1,822,579 2,033,876

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 429,207 331,208
Taxation and social security 736,809 563,281
Other creditors 750,261 1,206,155
1,916,277 2,100,644

6. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Factor advance 661,993 945,835

The factor advance is secured by a fixed and floating charge dated 24 August 2017 over the company's assets.

Company overdraft facilities are secured by a fixed and floating charge dated 15 June 2020 over the company's assets.

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

THE MEDICAL & DIAGNOSTIC CARE GROUP LTD (REGISTERED NUMBER: 09853305)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2024

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Stephen Cracknell FCA (Senior Statutory Auditor)
for and on behalf of ESW Limited

9. CONTINGENT LIABILITIES

The company has given a guarantee against the bank overdraft facilities to other group members.

10. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

11. PARENT COMPANY

The company's immediate and ultimate parent undertaking is GPS Medsol Holdings Limited, a company incorporated in England and Wales which is the smallest and largest group for which consolidated accounts including The Medical & Diagnostic Care Group Limited are prepared. The consolidated accounts of GPS Medsol Holdings Limited are available from its registered office, Amlin House, 90-96 Victoria Road, Chelmsford, CM1 1QU